Nanotechnology products often require regulatory approvals from bodies such as the FDA or EPA. Negotiating with these bodies involves presenting detailed safety and efficacy data. Understanding the regulatory framework and maintaining open channels of communication with regulatory authorities can facilitate smoother negotiations.
